Cargando…

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

Non–vitamin K oral anticoagulants have become the standard therapy for preventing stroke and ischemic thromboembolism in most patients with atrial fibrillation (AF). The effectiveness and safety of non–vitamin K oral anticoagulants in patients on hemodialysis is not well known. METHODS: From June 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reinecke, Holger, Engelbertz, Christiane, Bauersachs, Rupert, Breithardt, Günter, Echterhoff, Hans-Herbert, Gerß, Joachim, Haeusler, Karl Georg, Hewing, Bernd, Hoyer, Joachim, Juergensmeyer, Sabine, Klingenheben, Thomas, Knapp, Guido, Christian Rump, Lars, Schmidt-Guertler, Hans, Wanner, Christoph, Kirchhof, Paulus, Goerlich, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875840/ https://www.ncbi.nlm.nih.gov/pubmed/36335915 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.062779

Ejemplares similares

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018)

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
por: Haeusler, Karl Georg, et al.
Publicado: (2015)

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022)

Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis
por: Russ, Philipp, et al.
Publicado: (2019)

Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
por: Geisen, Christof, et al.
Publicado: (2010)

Drug interaction: Omeprazole and Phenprocoumon
por: Enderle, Christa, et al.
Publicado: (2001)

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis
por: Freisinger, Eva, et al.
Publicado: (2019)

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis
por: Engelbertz, Christiane, et al.
Publicado: (2023)

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial
por: Gottschalk, Sophie, et al.
Publicado: (2023)

Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation
por: Dickow, Jannis, et al.
Publicado: (2022)

Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis
por: Lange, Stefan A., et al.
Publicado: (2023)

AFNet Algorithm for Automatic Amniotic Fluid Segmentation from Fetal MRI
por: Costanzo, Alejo, et al.
Publicado: (2023)

Massive intoxication with rivaroxaban, phenprocoumon, and diclofenac: A case report
por: Pfeiffer, Hella, et al.
Publicado: (2016)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC – AFNET 9
por: Fabritz, Larissa, et al.
Publicado: (2022)

Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
por: Reinecke, Holger, et al.
Publicado: (2016)

Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry
por: Engelbertz, Christiane, et al.
Publicado: (2021)

Acute and Long-Term Outcomes of ST-Elevation Myocardial Infarction in Cancer Patients, a ‘Real World’ Analysis with 175,000 Patients
por: Lange, Stefan A., et al.
Publicado: (2021)

The effect of stopping phenprocoumon 5 days preoperatively: A retrospective study
por: Knol, Silke, et al.
Publicado: (2018)

Thrombosis of A Prosthetic Mitral Valve After Withdrawal of Phenprocoumon Therapy
por: Wilke, Andreas, et al.
Publicado: (2011)

The influence of excessive consumption of liquorice on phenprocoumon (Marcumar®): a case report
por: Roemer, Hermann Casper, et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Contemporary in-hospital and long-term prognosis of patients with acute ST-elevation myocardial infarction depending on renal function: a retrospective analysis
por: Engelbertz, Christiane, et al.
Publicado: (2023)

Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry
por: Zeymer, Uwe, et al.
Publicado: (2020)

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
por: Schnabel, Renate B, et al.
Publicado: (2022)

Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohort
por: Makowski, Lena, et al.
Publicado: (2022)

Status Quo – Die Anforderungen an die medizinische Habilitation in Deutschland
por: Strauss, Markus, et al.
Publicado: (2020)

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
por: Kirchhof, Paulus, et al.
Publicado: (2018)

Ketoprofen/phenprocoumon: Coagulation disorders, elevation in international normalised ratio and lack of efficacy: case report
Publicado: (2022)

Proceedings of the SFB-Workshop on C*-Algebras
por: Cuntz, Joachim, et al.
Publicado: (2000)

Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
por: Mülling, Nils, et al.
Publicado: (2021)

Resolution of left atrial appendage thrombi: No difference between phenprocoumon and non‐vitamin K‐dependent oral antagonists
por: Biller, Katharina, et al.
Publicado: (2022)

Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury
por: Kolbrink, Benedikt, et al.
Publicado: (2022)

Preparation of Apixaban Solid Dispersion for the Enhancement of Apixaban Solubility and Permeability
por: Lee, Juseung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a106j6gt874v7m2tb1qp3muksh